33 million people in the world are living with cancer today but many patients become resistant to treatment. Karl Ziegelbauer from Bayer looks at how collaborations between industry and academia help develop new cancer treatments.

To find out more, click here:   https://www.dddmag.com/news/2016/08/collaborating-advance-cancer-treatment